Microfluidic Chips Help Researchers Study How Metastatic Prostate Cancer Spreads

Researcher Gevick Safarians is using innovative microfluidic chip technology to simulate the complex environments that metastatic prostate cancer cells travel through in the body. Inspired by conversations with cancer patients facing limited time, his work aims to better understand how cancer spreads and develops resistance to treatment. This research could lead to more effective therapies for advanced prostate cancer, one of the leading causes of cancer death in men. By recreating the biological conditions cancer encounters, scientists can test how tumors adapt and survive, potentially opening new avenues for personalized treatment strategies that improve patient outcomes.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: September 22, 2026 at 10:01 AM



